I was referring to a comment made by the CEO.
Mr. Waldrop also said, "Another positive as a result of the accreditation process is there are fewer labs in the state that we now consider competition. As a result, we have adjusted our annual average revenue projections for our Oregon accounts upward by more than 50% from $1,089 to $1,731 per customer. Once we close on our Portland acquisition, we will be fully capable of covering 95% of the entire market."